Alvomedical has evolved and now primarily operates under the brand Adalvo. Adalvo is a global pharmaceutical company with a B2B focus, partnering with pharmaceutical companies worldwide. They specialize in the development, licensing, and supply of a broad portfolio of high-quality generic and specialty pharmaceuticals, including complex formulations and value-added medicines across various therapeutic areas. Adalvo aims to improve patient access to affordable and advanced treatments through its extensive network and expertise in the pharmaceutical value chain.
Global operational headquarters managing B2B pharmaceutical development, strategic partnerships, licensing, and worldwide supply chain operations.
Located in 'The Hive,' a modern business center, suggesting state-of-the-art facilities designed for collaboration and innovation.
A dynamic, fast-paced, and results-oriented environment focused on global collaboration, innovation in pharmaceutical solutions, and strong B2B partnerships.
Serves as the central hub for Adalvo's global strategy, decision-making, and coordination of its international commercial and development activities.
Adalvo, formerly Alvomedical, maintains a significant global presence, supporting worldwide pharmaceutical operations through its B2B platform. This includes drug development, intellectual property management, manufacturing oversight, regulatory support, and commercial partnerships in over 100 countries across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The Hive, Triq Schembri
Msida
MSD 1019 (Postal Code)
Malta
Address: Adalvo AG, Baarerstrasse 139, 6300 Zug, Switzerland
Facilitates Adalvo's engagement with European partners, manages financial operations, and supports regulatory affairs within the region.
Address: c/o Arene Lifesciences (Group Company), Plot No. 23-25 & 36, Sy No.10, GMR Aerospace & Industrial Park, Mamidipally, Hyderabad – 500008, Telangana, India
Leverages India's pharmaceutical manufacturing and development capabilities to support Adalvo's global product portfolio and supply chain efficiency for Asian and global markets.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, ALVO Medical' leadership includes:
ALVO Medical has been backed by several prominent investors over the years, including:
Adalvo has strategically enhanced its leadership over the past 12 months with key appointments in legal and finance, alongside internal promotions to bolster commercial leadership, reflecting its commitment to growth and operational excellence. No major executive departures have been publicly announced.
Discover the tools ALVO Medical uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Adalvo typically utilizes standard professional email formats for its employees, most commonly combining the employee's first and last name or first initial and last name with the adalvo.com domain.
[first].[last]@adalvo.com or [first_initial][last]@adalvo.com
Format
jane.doe@adalvo.com
Example
85%
Success rate
Adalvo Website / PR Newswire • May 16, 2024
Adalvo, in partnership with JabloPharm, has successfully launched Lenalidomide capsules (equivalent to Revlimid®) in Poland, marking a significant step in expanding access to critical oncology treatments within the Polish market....more
Adalvo Website / Cision PR Newswire • May 7, 2024
Adalvo announced a new strategic partnership to develop and commercialize a biosimilar product (equivalent to Tysabri®) aimed at treating Multiple Sclerosis, further strengthening its complex product portfolio and commitment to providing high-value medicines....more
Adalvo Website • April 23, 2024
Adalvo has received Decentralized Procedure (DCP) approval for Apremilast 10mg, 20mg, and 30mg film-coated tablets, a generic equivalent to Otezla®, for treating psoriatic arthritis, psoriasis, and Behçet's disease, with patent certification in multiple European countries....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including ALVO Medical, are just a search away.